洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2400084947】Computer Use for Seniors on Mood Improvement and Logic Enhancement (CU-SMILE)

基本信息
登记号

ChiCTR2400084947

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2024-05-28

临床申请受理号

/

靶点

/

适应症

Depression

试验通俗题目

Computer Use for Seniors on Mood Improvement and Logic Enhancement (CU-SMILE)

试验专业题目

Computer Use for Seniors on Mood Improvement and Logic Enhancement (CU-SMILE)

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

To improve mood symptoms in community-living older adults with depression using computerized cognitive training

试验分类
试验类型

单臂

试验分期

其它

随机化

No randomization is needed, as this study only has one arm

盲法

/

试验项目经费来源

Knowledge Transfer Project Fund (KPF) of the Chinese University of Hong Kong, and Social Innovation and Entrepreneurship Development Fund (SIE Fund) of the Government of HKSAR

试验范围

/

目标入组人数

160

实际入组人数

/

第一例入组时间

2024-06-01

试验终止时间

2026-03-31

是否属于一致性

/

入选标准

Inclusion criteria are community-living Chinese individuals aged 60 years and older, and having a primary diagnosis of major depressive disorder (single or recurrent episodes without psychotic features) based on the DSM-5 criteria, with cognitive symptoms [Item 8 (slowness of thought and speech, impaired ability to concentrate) score ≥2 in HAM-D], but without dementia (based on the age- and education-specific cutoff of HK-MoCA).;

排除标准

Individuals who have suicidal idea, psychotic symptom, or are treatment-resistant [history of electroconvulsive therapy, transcranial magnetic stimulation, or no clinical response to ≥2 different classes of antidepressants] will be excluded and referred to the psychiatric services of the Hospital Authority. Other exclusion criteria are non-Chinese; living in care homes; having history or ongoing substance abuse (including alcohol), mania, bipolar or psychotic disorder, posttraumatic stress disorder, anxiety disorder, personality disorder, or mental disorder due to organic cause; having history of traumatic brain injury, Parkinson’s disease, stroke, dementia, or scoring below HK-MoCA cutoff; or having language barrier or impairment in communication (poor vision or hearing despite correction).;

研究者信息
研究负责人姓名
试验机构

香港中文大學

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

香港中文大學的其他临床试验

香港中文大學的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品